On the basis of these findings, we conclude that these variants can be considered pathogenic for SPG18, broadening the genetic spectrum of type 18 HSP and facilitating the diagnosis of similar cases in the future. The gene discussed is ERLIN2; the disease is hereditary spastic paraplegia.